Overview


According to FutureWise analysis the market for pneumococcal testing in 2023 is US$ 1.78 billion, and is expected to reach US$ 4.23 billion by 2031 at a CAGR of 11.4%.

There has been a substantial rise in the number of pneumococcal testing across the world with the current COVID-19 pandemic. Rising emphasis on molecular diagnostics for detecting respiratory pathogens has resulted in the pneumococcal testing market growth to a substantial level. Furthermore, this testing has gained clinical importance with respect to the ability of demonstrating high analytical specificity and sensitivity along with the capability of processing multiple respiratory specimens. The point of care testing is generally preferred as the conventional testing technique. This can be credited to the increased necessity to offer real-time results that aid the physicians to make correct decisions in the disease treatment. Furthermore, these tests are used for medical care has shifted focus on early detection, prevention and managing chronic conditions.

  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • F-Hoffmann la Roche Ltd.
  • Hologic Inc.
  • bioMerieux
  • Becton Dickenson and Company
  • Bio-Rad Laboratories Inc.
  • Meridian Biosciences
  • Quest Diagnostics
  • Quidel

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Method

  • Immunodiagnostics
  • Molecular Diagnostics
  • Point of Care Testing

By Technology

  • Enzyme Linked Immunosorbent Assay
  • Immunofluorescence
  • Western Blot
  • Polymerase Chain Reaction
  • Immunohistochemistry
  • Others

By End User

  • Hospitals
  • Homecare
  • Diagnostic Laboratories
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

The market is categorised into method, technology, end user and region. The method segment is fragmented into immunodiagnostics, molecular diagnostics and point of care diagnostics. The point of care testing market held the largest pneumococcal testing market share during the forecast period as this method can test multiple samples at once which provides efficient workflow for healthcare organizations. The technology segment is bifurcated into enzyme linked immunohistochemistry, immunofluorescence, polymerase chain reaction, western block and others. The end user segment is classified into hospital, diagnostic laboratories, homecare and others. The hospital segment is anticipated to lead the market owing to a rise in the number of patients diagnosed with pneumococcal symptoms with the ongoing COVID-19 pandemic.

The North America region is predicted to dominate the market during the forecast period owing to a strong presence of key market players in the region, growing investments for research and development in pneumococcal testing methodologies. The Asia Pacific region, on the other hand, is expected to lead the market owing to increased demand for these tests with the rising geriatric population in countries like Japan, China.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global Pneumococcal Testing Market By Method, By Technology, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework on Country Level
         6.1 . Reimbursement Framework
         6.2 . Standards and Compliances

  • 5.   Market Overview

    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Neurorehabilitation Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.   Market Analysis tools
    •   1. Industry Analysis - Porter’s
         1.1 . Supplier Power
         1.2 . Buyer Power
         1.3 . Substitution Threat
         1.4 . Threat from new entrants
         1.5 . Competitive Rivalry
        2. Pestel Analysis
         2.1 . Political Landscape
         2.2 . Environmental Landscape
         2.3 . Social landscape
         2.4 . Technology landscape
         2.5 . Legal Landscape
  • 7.   Pneumococcal Testing Market, By Method Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Immunodiagnostics
        2. Molecular Diagnostics
        3. Point of Care Testing

  • 8.   Pneumococcal Testing Market, By Technology Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Enzyme Linked Immunosorbent Assay
        2. Immunofluorescence
        3. Western Blot
        4. Polymerase Chain Reaction
        5. Immunohistochemistry
        6. Others

  • 9.   Pneumococcal Testing Market, By End User Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Hospitals
        2. Homecare
        3. Diagnostic Laboratories
        4. Others

  • 10.   North America Pneumococcal Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Mn) Analysis By Country, 2017-2022
         2.1. U.S.
         2.2. Canada
         2.3. Mexico
         2.4 . Rest of North America
        3. Market Size (USD Mn) Forecast for North America 2023-2031

  • 11.   Latin America Pneumococcal Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (US$ Mn) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Uruguay
         3.3 . Argentina
         3.4. Rest of Latin America
        4. Market Size (US$ Mn) Forecast for Latin America 2023-2031

  • 12.   Europe Pneumococcal Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (US$ Mn) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5 . Switzerland
         2.6. Spain
         2.7. Russia
         2.8. Poland
         2.9. Rest of Western Europe
        3. Market Size (US$ Mn) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Pneumococcal Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Mn) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. Korea
         2.5. India
         2.6. Australia and New Zealand
         2.7. ASEAN
         2.8. Rest of Asia Pacific
        3. Market Size (US$ Mn) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Mn) Analysis By Country, 2017-2022
         2.1. UAE
         2.2. South Africa
         2.3. Egypt
         2.4. Saudi Arabia
         2.5. Rest of MEA
        3. Market Size (US$ Mn) Forecast for MEA 2023-2031

  • 15.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)

    •   1. Thermo Fisher Scientific Inc.
         1.1. Company Overview (HQ, Business Segments, Employee Strength)
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbott Laboratories
         2.1. Company Overview (HQ, Business Segments, Employee Strength)
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. F-Hoffmann la Roche Ltd.
         3.1. Company Overview (HQ, Business Segments, Employee Strength)
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Hologic Inc.
         4.1. Company Overview (HQ, Business Segments, Employee Strength)
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. bioMerieux
         5.1. Company Overview (HQ, Business Segments, Employee Strength)
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Becton Dickenson and Company
         6.1. Company Overview (HQ, Business Segments, Employee Strength)
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Bio-Rad Laboratories Inc.
         7.1. Company Overview (HQ, Business Segments, Employee Strength)
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Meridian Biosciences
         8.1. Company Overview (HQ, Business Segments, Employee Strength)
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Quest Diagnostics
         9.1. Company Overview (HQ, Business Segments, Employee Strength)
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Quidel
         10.1. Company Overview (HQ, Business Segments, Employee Strength)
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   Competitive Intelligence and Competitive Matrix

    •   1. Competitive Intelligence
        2. Competitive Matrix

  • 19.   Major Deals and Strategic Alliances Analysis

    •   1. Joint ventures
        2. Mergers and acquisitions
        3. Licensing and partnerships
        4. Technology Collaborations
        5. Strategic Divestments
        6. Market Entry Strategies
       

  • 20.   Relevant Case Studies and Latest News Updates

    •   

  • 21.  Key Market Takeaway Points from the Market Analysts at Future Market Analytics

    •   


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11